Diabetics have fewer cardiovascular events with metformin than with glipizide

NEW YORK (Reuters Health) - Compared with glipizide, long-term therapy with metformin leads to a
reduction in major cardiovascular events in patients with type 2 diabetes, according to Chinese and US
researchers.

Source: Modern Medicine - January 1, 2013 Category: Journals (General) Source Type: news